Cataract is the main cause of blindness around the world. The older generation is primarily affected; in around 90 percent of the cases, this disease occurs with old age. Colloquially, it is known as age-related cataract. The disease begins as a gray veil that initially impairs vision and then leads to blindness.
The good news: the affected lenses can be replaced with artificial lenses in an uncomplicated surgical procedure. In Germany alone, almost a half million cataract procedures are performed every year. Technology from Carl Zeiss supports this procedure with a new instrument: Visalis 100 removes the diseased crystalline lens of the eye using the phaco-emulsification technique with ultrasound and suction. From the diagnostics instrument to intraocular lenses, surgical microscopes and follow-up devices, Carl Zeiss provides a complete line for the treatment of cataract.
The new Visalis 100 system is already being used in India where its ease of use and absolute precision have made it a star. Innovations for growth markets are in demand, particularly in Asia where there is considerable need for medical devices for ophthalmology. Carl Zeiss actively participates in fighting preventable blindness and in the advancement of eye care in developing regions. The company’s contribution to the "Vision 2020 — The Right to Sight" project makes it possible to help those most in need.
September 8, 2009